Techno-economic analysis: what the model finds
The MCS Playbook asks three questions of every climate intervention: what is the technical potential, what does abatement cost, and where does uncertainty live? For this AMC, the answers are unusually strong across all three.
At $3.21 per tonne avoided, this AMC delivers abatement at roughly one-tenth the price of voluntary carbon market credits, which typically trade between $10 and $40 per tonne. The economic case is not marginal.
▶ Key modeling assumptions
| Assumption | Value |
|---|---|
| Efficacy (methane reduction) | 20% conservative baseline (TPP target: 50%) |
| Adoption rate | 25% conservative · 50% central scenario |
| Target population | 90M U.S. cattle |
| Program horizon | 10 years |
| AMC tail price | $16.40 per dose |
| Social cost of methane | $1,500 per tonne CH₄ (GWP-100) |
| Discount rate | 7% (OMB guidance) |
Lifecycle assessment
A simplified LCA evaluates whether the lifecycle emissions of vaccine production and deployment are justified by the methane abatement achieved. The short answer is: decisively yes, by roughly two orders of magnitude.
▶ System boundary
The LCA boundary encompasses five stages: R&D inputs (lab energy, materials, clinical trials), manufacturing (bioreactor energy, raw materials, cold chain), distribution (transport to farms, refrigeration), administration (veterinary labor, animal handling), and the use phase (methane reduction over the animal's productive lifespan). End-of-life considerations are minimal since the vaccine is metabolized by the animal.
Methane reduction
Net lifecycle impact: overwhelmingly positive
Key finding
Each vaccinated animal avoids approximately 0.014 tCH₄ per year (0.392 tCO₂e at GWP-100). Vaccine manufacturing and distribution emissions are estimated at low single-digit kg CO₂e per dose. The ratio of avoided to embodied emissions is on the order of 100:1 or greater. This intervention is not a marginal improvement on the emissions ledger.
▶ Methodology & literature
Methodological approach ISO 14040/14044 (UC Berkeley MCS, Prof. Matthew Potts). Functional unit: one completed vaccination course per animal per year. System boundary: cradle-to-use-phase. Impact category: GWP-100. Primary sources: FAO GLEAM, EPA GHG Inventory (2024), Jensen et al. (2014) veterinary cost dataset.
Pathways and barriers
Sociotechnical transitions theory asks why promising technologies fail to scale even when the economics are sound. For a methane vaccine, the answer is structural: no incumbent regime punishes inaction, so no private actor has sufficient incentive to move first. The AMC is designed specifically to solve this coordination failure.
▶ Transitions framework context
In transition theory terms, enteric methane reduction is a niche technology attempting to disrupt an established regime (conventional livestock production with no methane pricing). The regime is stable because producers face no financial penalty for methane emissions and no financial reward for reducing them. The AMC functions as a niche-stimulation mechanism: it creates an artificial demand signal that allows the niche to develop without requiring the regime itself to change first.
This framing is drawn from the Multi-Level Perspective (Geels, 2002) and the Strategic Niche Management literature (Kemp et al., 1998), as applied in the UC Berkeley MCS curriculum analytical framework.
Structural barriers
Of the five barriers, two are structurally resolved by the AMC mechanism, two are partially mitigated through program design, and one remains open. The open challenge is the binding constraint on coalition formation.
Co-benefits analysis
In the current political environment, non-climate co-benefits are often the critical path to adoption. An intervention that can be framed as a rural development investment, a trade competitiveness tool, or a food security measure commands a broader coalition than one framed solely as climate mitigation. Five dimensions are under active analysis for the final deliverable.
▶ Dimensions under analysis
AMC design: governance architecture
The most consequential design choice in an AMC is not the commitment size or the tail price. It is when in the product development cycle the capital commitment is made, and what obligations it creates before a product exists. Two architectures are viable for a methane vaccine AMC.
▶ Key design parameters
Four parameters set the economic terms of the commitment regardless of which architecture is chosen.
The next question
This analysis stress-tests one mechanism in depth. The next question is which mechanism fits which market, time horizon, and risk appetite. Phase 2 of this work addresses that directly.
The Spark Enteric Methane Navigator maps 15+ market mechanism types across funder profiles, market stages, and political contexts. It helps decision-makers identify where an AMC, carbon credit, subsidy, results-based finance, or regulatory instrument is most likely to succeed, and why. Explore the Navigator →